Business & Finance
AstraZeneca advances weight-loss pill to take aim at obesity leaders
Key Points
Pill from drugmaker would put it into competition with market leaders Novo Nordisk and Eli Lilly
Pill from drugmaker would put it into competition with market leaders Novo Nordisk and Eli Lilly